Comparative study of three types of anesthesia on postoperative pain after colon surgery

Conditions: Postoperative pain
MedDRA version: 14.1Level: LLTClassification code 10054711Term: Postoperative painSystem Organ Class: 100000004863
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

Registration Number: EUCTR2013-000556-17-ES

Lead Sponsor: Fundació Parc Taulí

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Authorised-recruitment may be ongoing or finished

Sex: All

Target Recruitment: Not specified

Inclusion Criteria

age 18 years, informed consent of the study, patients without contraindication for performance of any of the three analgesic techniques.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 70
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 140

Exclusion Criteria

emergency surgery, impaired higher functions, ASA IV patients, chronic treatment with opioids.

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Primary objective: To determine the effectiveness of three analgesic techniques used in the control of postoperative pain after laparoscopic sigmoidectomy and determine which one offers a lower incidence of adverse effects.;Secondary Objective: Secondary objective: To compare time from surgery until discharge depending on the type of analgesia used.; Compare the total economic cost in terms of the drugs administered, staff involved and hospital stay.;Primary end point(s): Primary endpoint: pain control in the first 48 hours postoperatively;Timepoint(s) of evaluation of this end point: First 48 hours postoperatively

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): Secondary variables: presence of ileus, lower extremity paresthesias, nausea or vomiting, acute urinary retention, respiratory depression, hypotension. Economic costs.;Timepoint(s) of evaluation of this end point: Up to patient discharge